IP Library Granted Patent US 8,741,222
Granted Patent B2
US 8,741,222 · App. 14/107,535 · Granted Jun 3, 2014

Conversion of nitrogen dioxide (NO

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,741,222
App. No.
14/107,535
Granted
Jun 3, 2014
Kind
B2
Abstract

Various systems, devices, NO 2 absorbents, NO 2 scavengers and NO 2 recuperator for generating nitric oxide are disclosed herein. According to one embodiment, an apparatus for converting nitrogen dioxide to nitric oxide can include a receptacle including an inlet, an outlet, a surface-active material coated with an aqueous solution of ascorbic acid and an absorbent wherein the inlet is configured to receive a gas flow and fluidly communicate the gas flow to the outlet through the surface-active material and the absorbent such that nitrogen dioxide in the gas flow is converted to nitric oxide.

Claims (14)

1. A system of delivering a therapeutic amount of nitric oxide to a mammal comprising:

a ventilator,

an NO 2 scavenger selected from the group consisting of proline, diphenylamine, a secondary amine and a tertiary amine, and

a receptacle including an inlet, an outlet, and a surface-active material;

wherein the surface-active material includes an absorbent and a reducing agent; and

wherein the inlet is configured to receive a gas flow and fluidly communicate the gas flow to the outlet through the surface-active material, such that nitrogen dioxide in the gas flow is converted to nitric oxide.

2. The system of claim 1 , wherein the absorbent is silica gel.

3. The system of claim 1 , wherein the absorbent is activated alumina.

4. The system of claim 1 , further comprising a gas source of nitrogen dioxide, dinitrogen tetraoxide, or nitric oxide.

5. The system of claim 1 , further comprising a gas source of nitric oxide.

6. The system of claim 1 , wherein the receptacle includes the NO 2 scavenger.

7. The system of claim 1 , further comprising a humidified line.

8. The system of claim 7 , wherein the humidified line is heated.

9. The system of claim 7 , wherein the humidified line is heated to about 35° C.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Mar 18, 2026
From: HORIZON TECHNOLOGY FINANCE CORPORATION
To: VERO BIOTECH INC.
Reel/Frame 075308/0198 →
SECURITY INTEREST Recorded Mar 16, 2026
From: VERO BIOTECH INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS COLLATERAL AGENT
Reel/Frame 075117/0935 →
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 3, 2024
From: RUNWAY GROWTH FINANCE CORP (F/K/A RUNWAY GROWTH CREDIT FUND INC.)
To: VERO BIOTECH INC. (F/K/A VERO BIOTECH LLC)
Reel/Frame 066186/0611 →
SECURITY INTEREST Recorded Jan 3, 2024
From: VERO BIOTECH INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 066187/0865 →
CHANGE OF NAME Recorded Feb 14, 2022
From: VERO BIOTECH LLC
To: VERO BIOTECH INC.
Reel/Frame 059085/0418 →
SECURITY INTEREST Recorded Dec 29, 2020
From: VERO BIOTECH LLC
To: RUNWAY GROWTH CREDIT FUND INC.
Reel/Frame 054866/0589 →
CHANGE OF NAME Recorded Jun 6, 2018
From: GENO LLC
To: VERO BIOTECH LLC
Reel/Frame 046304/0855 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2013
From: FINE, DAVID H.; VASQUEZ, GREGORY; ROUNBEHLER, DAVID P.
To: GENO LLC
Reel/Frame 031817/0371 →